MAPT and Alzheimer disease: According to the 2021 International Working Group (IWG) diagnostic criteria, the patient was diagnosed with probable AD, supported by his cerebrospinal fluid test was positive for Aβ amyloid but negative for tau protein (Dubois et al., 2021).